Cargando…

Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) are at high risk of cardiovascular mortality, but the mechanisms behind this remain unclear. Prothrombotic fibrin clot properties have been shown in T2DM and cardiovascular disease. We hypothesized that formation of denser clots, which are re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bryk, Agata Hanna, Konieczyńska, Małgorzata, Polak, Maciej, Plicner, Dariusz, Bochenek, Maciej, Undas, Anetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893920/ https://www.ncbi.nlm.nih.gov/pubmed/33602240 http://dx.doi.org/10.1186/s12933-021-01230-9

Ejemplares similares

Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study
por: Paszek, Elżbieta, et al.
Publicado: (2023)

Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
por: Gajos, Grzegorz, et al.
Publicado: (2015)

Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease
por: Bochenek, Maciej, et al.
Publicado: (2012)

Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
por: Bryk, Agata H., et al.
Publicado: (2019)

Elevated lipoprotein(a) as a new risk factor of cerebral venous sinus thrombosis: association with fibrin clot properties
por: Skuza, Anna Aleksandra, et al.
Publicado: (2018)

Faster fibrin clot degradation characterizes patients with central pulmonary embolism at a low risk of recurrent peripheral embolism
por: Kupis, Robert W., et al.
Publicado: (2019)

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Increased Oxidation as an Additional Mechanism Underlying Reduced Clot Permeability and Impaired Fibrinolysis in Type 2 Diabetes
por: Lados-Krupa, Anna, et al.
Publicado: (2015)

Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2018)

Unexplained thrombosis of the aortic arch with distal embolization in a patient with altered fibrin clot properties
por: Ciurus, Tomasz, et al.
Publicado: (2012)

Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal Contraception
por: Piróg, Magdalena, et al.
Publicado: (2019)

Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein
por: Szułdrzyński, Konstanty, et al.
Publicado: (2020)

Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes
por: Ząbczyk, Michał, et al.
Publicado: (2021)

Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia
por: Nowakowski, Tomasz, et al.
Publicado: (2019)

Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype
por: Natorska, Joanna, et al.
Publicado: (2023)

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence
por: Undas, Anetta
Publicado: (2017)

Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study
por: Polak, Maciej Wiktor, et al.
Publicado: (2019)

Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
por: Bryk-Wiązania, Agata Hanna, et al.
Publicado: (2021)

Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study
por: Mrozinska, Sandra, et al.
Publicado: (2021)

Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism
por: Stachowicz, Aneta, et al.
Publicado: (2017)

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008)

8-Isoprostanes and Asymmetric Dimethylarginine as Predictors of Mortality in Patients Following Coronary Bypass Surgery: A Long-Term Follow-Up Study
por: Gołąb, Aleksandra, et al.
Publicado: (2022)

Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation
por: Gajos, Grzegorz, et al.
Publicado: (2018)

Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation
por: Ząbczyk, Michał, et al.
Publicado: (2020)

Specific changes in circulating cytokines and growth factors induced by exercise stress testing in asymptomatic aortic valve stenosis
por: Kolasa-Trela, Renata, et al.
Publicado: (2017)

Properties of Plasma Clots in Adult Patients Following Fontan Procedure: Relation to Clot Permeability and Lysis Time—Multicenter Study
por: Skubera, Maciej, et al.
Publicado: (2021)

P1699: ANTITHROMBIN DEFICIENCY IS ASSOCIATED WITH PROTHROMBOTIC FIBRIN CLOT PHENOTYPE
por: Zabczyk, M., et al.
Publicado: (2022)

Fibrin Clot Formation and Lysis in Plasma
por: Larsen, Julie Brogaard, et al.
Publicado: (2020)

Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia
por: Mastalerz, Lucyna, et al.
Publicado: (2015)

Fibrinogen Beta-Chain -C148T Polymorphism is Associated with Increased Fibrinogen, C-Reactive Protein, and Interleukin-6 in Patients Undergoing Coronary Artery Bypass Grafting
por: Wypasek, Ewa, et al.
Publicado: (2011)

Increased Plasma Clot Permeability and Susceptibility to Lysis Are Associated with Heavy Menstrual Bleeding of Unknown Cause: A Case-Control Study
por: Szczepaniak, Piotr, et al.
Publicado: (2015)

Acute-phase proteins and oxidative stress in patients undergoing coronary artery bypass graft: comparison of cardioplegia strategy
por: Plicner, Dariusz, et al.
Publicado: (2017)

Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation
por: Ząbczyk, Michał, et al.
Publicado: (2023)

Identification of Fibrin Clot-Bound Plasma Proteins
por: Talens, Simone, et al.
Publicado: (2012)

Unfavourably altered plasma clot properties in patients with primary Raynaud’s phenomenon: association with venous thromboembolism
por: Żuk, Joanna, et al.
Publicado: (2019)

Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease
por: Poreba, Malgorzata, et al.
Publicado: (2018)

Preoperative values of inflammatory markers predict clinical outcomes in patients after CABG, regardless of the use of cardiopulmonary bypass
por: Plicner, Dariusz, et al.
Publicado: (2016)

Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes
por: Poreba, Malgorzata, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h8ms3ci6u8u6lpjrq39jsgd512